Former Wallabies hooker Nathan Charles, a former Australian rugby international who famously battled cystic fibrosis to carve out a professional career in a high‑impact sport, has recently disclosed that he has been diagnosed with motor neurone disease (MND). At 37 years old, Charles—who earned his first Test cap in 2014 and went on to collect four appearances for the national side, including a memorable 12‑12 stalemate against the All Blacks—announced that his condition mirrors the diagnosis recently announced by retired NRL star Jai Arrow.
MND is a collective term for a range of progressive neurological disorders that cause the motor neurons controlling voluntary muscle movement to deteriorate over time. The most prevalent form is amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig’s disease. Both conditions are fatal and currently have no cure, leaving patients to cope with a relentless loss of physical function.
Charles opened up about his diagnosis during a candid interview with former Wallabies lock‑turned‑broadcaster Justin Harrison on Stan Sport earlier this week. He explained that the confirmation came only after a protracted period of uncertainty. "For a long period there I just didn't know what it was," Charles said, reflecting on the months of medical tests and specialist consultations that yielded no clear answers.
"I've had many tests and seen many doctors, but we just weren't getting any answers. My health just kept declining." He continued, "And then recently, in the last few weeks, I was actually diagnosed with motor neurone disease, which has been extremely challenging and overwhelming. I know there's no cure and … your physicality, your body deteriorates and, yeah, your life cuts short." The former professional retired from the game in 2018 after stints with the Perth‑based Western Force and the Melbourne Rebels in Super Rugby, as well as overseas spells with Gloucester, Bath and Wasps in England’s Premiership.
Since hanging up his boots, Charles has remained involved in the sport, serving as chief executive of Rugby Western Australia and contributing to the Sydney University Rugby Club’s administration. His announcement joins a growing list of high‑profile rugby figures who have been affected by MND. Former England captain and 2003 World Cup winner Lewis Moody received his diagnosis last year, while the sport has also mourned the loss of England’s Rob Burrow and Scottish legend Doddie Weir, both of whom succumbed to the disease. Charles’s own health journey began long before his rugby career.
He revealed on his personal website that he was diagnosed with cystic fibrosis at just three months old—a genetic disorder that primarily impairs lung function and digestion. Doctors at the time warned that his life expectancy might not extend beyond his tenth birthday.
Defying those grim predictions, Charles not only survived but thrived, eventually reaching the pinnacle of Australian rugby. "I am constantly pushing the boundaries and am living proof that anything is possible," he wrote in a social‑media post aimed at raising awareness of both cystic fibrosis and MND. "It is my personal mission to truly exceed the life expectancy of 37 years [which is the life expectancy of people with CF]." Now, facing a second, incurable illness, Charles expressed a mixture of resilience and irony. "I was born with a life‑threatening illness.
I've given that a red‑hot crack. Now this other thing comes along," he said. "I find it quite ironic that something else will strike me down rather than what I've been dealing with for my whole life." The Australian rugby community quickly rallied around their former teammate.
The Wallabies, who are currently preparing for the upcoming Bledisloe Cup series against New Zealand, posted a supportive message on their official social channels. Team captain Harry Wilson added, "We know you have a tough time ahead, but we're with you every step of the way." While there is no cure for MND, research into treatments and supportive therapies continues worldwide. Advocacy groups stress the importance of early diagnosis, multidisciplinary care, and funding for scientific studies aimed at slowing disease progression.
Charles’s public disclosure is expected to shine a spotlight on these efforts, encouraging fans and fellow athletes to contribute to fundraising and awareness campaigns. In the broader context, Charles’s story underscores the unpredictable nature of health challenges faced by elite athletes. Even those who have demonstrated extraordinary physical resilience can be vulnerable to conditions that lie beyond the reach of training, nutrition, and medical expertise. His willingness to share his journey publicly not only humanizes the struggle but also offers hope to others living with chronic illnesses, reminding them that perseverance and community support remain powerful tools in the face of adversity.
As the Wallabies gear up for their high‑stakes matches against the All Blacks, the team’s solidarity with Charles serves as a poignant reminder that the bonds forged on the field often extend far beyond the final whistle. His courage in confronting a devastating diagnosis, coupled with his lifelong battle against cystic fibrosis, paints a portrait of a man who continually redefines the limits of what is possible, inspiring both teammates and supporters worldwide.